Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -39.33 | 40.75 |
| PEG Ratio (TTM) | 7.37 | 6.23 |
| P/S Ratio (TTM) | 1.09 | 1.58 |
| P/B Ratio (TTM) | 1.71 | 5.88 |
| P/FCF Ratio (TTM) | 40.09 | 21.70 |
| Price to 5YR AVG Earnings Ratio | N/A | 49.33 |
| Price to 5YR AVG FCF Ratio | N/A | 61.13 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.13% | 6.32% |
| ROE (TTM) | -5.23% | 19.10% |
| Net Profit Margin (TTM) | -2.60% | 4.49% |
| ROIC 5YR AVG | N/A | 14.07% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -158.18% | 541.52% | N/A |
| Revenue | 4.92% | 34.90% | N/A |
| Net Income | -142.14% | 489.66% | N/A |
| Cash Flow | 149.17% | 23.09% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.43 | 16.99 |
| Quick Ratio (TTM) | 1.43 | 16.93 |
| D/E Ratio (TTM) | 0.23 | 0.66 |
| Interest Coverage (TTM) | -4.13 | 24.54 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | 1.82 | 4.29 |
| LTL to 5YR AVG FCF | N/A | 6.74 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.79% |